110 related articles for article (PubMed ID: 18574773)
1. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
[TBL] [Abstract][Full Text] [Related]
2. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
[TBL] [Abstract][Full Text] [Related]
3. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
Tam YK; Martinson JA; Doligosa K; Klingemann HG
Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
[TBL] [Abstract][Full Text] [Related]
5. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.
Lemoine FM; Mesel-Lemoine M; Cherai M; Gallot G; Vié H; Leclercq V; Trébèden-Negre H; Mammès O; Boyer O; Noguiez-Hellin P; Klatzmann D
J Gene Med; 2004 Apr; 6(4):374-86. PubMed ID: 15079812
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.
Ayuk F; Li Z; Kühlcke K; Lindemann C; Schade U; Eckert HG; Zander A; Fehse B
Gene Ther; 1999 Oct; 6(10):1788-92. PubMed ID: 10516731
[TBL] [Abstract][Full Text] [Related]
7. Optimized retroviral transduction protocol which preserves the primitive subpopulation of human hematopoietic cells.
Tonks A; Tonks AJ; Pearn L; Mohamad Z; Burnett AK; Darley RL
Biotechnol Prog; 2005; 21(3):953-8. PubMed ID: 15932279
[TBL] [Abstract][Full Text] [Related]
8. An efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking.
Dodo K; Chono H; Saito N; Tanaka Y; Tahara K; Nukaya I; Mineno J
PLoS One; 2014; 9(1):e86275. PubMed ID: 24454964
[TBL] [Abstract][Full Text] [Related]
9. Single-step, multiple retroviral transduction of human T cells.
Abad JL; Serrano F; San Román AL; Delgado R; Bernad A; González MA
J Gene Med; 2002; 4(1):27-37. PubMed ID: 11828385
[TBL] [Abstract][Full Text] [Related]
10. Artificial capillary culture: expansion and retroviral transduction of CD4+ T-lymphocytes for clinical application.
Knop AE; Arndt AJ; Raponi M; Boyd MP; Ely JA; Symonds G
Gene Ther; 1999 Mar; 6(3):373-84. PubMed ID: 10435087
[TBL] [Abstract][Full Text] [Related]
11. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
[TBL] [Abstract][Full Text] [Related]
12. Efficient gene transfer into primary human natural killer cells by retroviral transduction.
Guven H; Konstantinidis KV; Alici E; Aints A; Abedi-Valugerdi M; Christensson B; Ljunggren HG; Dilber MS
Exp Hematol; 2005 Nov; 33(11):1320-8. PubMed ID: 16263416
[TBL] [Abstract][Full Text] [Related]
13. Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications.
Yuan J; Kendle R; Ireland J; Heller G; Sadelain M; Young JW; Rivière I
J Immunother; 2007 Sep; 30(6):634-43. PubMed ID: 17667527
[TBL] [Abstract][Full Text] [Related]
14. High efficiency closed-system gene transfer using automated spinoculation.
Remley VA; Jin J; Sarkar S; Moses L; Prochazkova M; Cai Y; Shao L; Liu H; Fuksenko T; Jin P; Stroncek DF; Highfill SL
J Transl Med; 2021 Nov; 19(1):474. PubMed ID: 34819105
[TBL] [Abstract][Full Text] [Related]
15. Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
Lamers CH; Willemsen RA; van Elzakker P; van Krimpen BA; Gratama JW; Debets R
Cancer Gene Ther; 2006 May; 13(5):503-9. PubMed ID: 16282986
[TBL] [Abstract][Full Text] [Related]
16. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity.
Tran CA; Burton L; Russom D; Wagner JR; Jensen MC; Forman SJ; DiGiusto DL
J Immunother; 2007 Sep; 30(6):644-54. PubMed ID: 17667528
[TBL] [Abstract][Full Text] [Related]
17. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
[TBL] [Abstract][Full Text] [Related]
18. Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors.
Gagliardi C; Khalil M; Foster AE
Cytotherapy; 2019 Dec; 21(12):1246-1257. PubMed ID: 31837737
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells.
Lamana ML; Segovia JC; Guenechea G; Bueren JA
J Gene Med; 2001; 3(1):32-41. PubMed ID: 11269334
[TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transfer into primary human natural killer cells.
Alici E; Sutlu T; Sirac Dilber M
Methods Mol Biol; 2009; 506():127-37. PubMed ID: 19110624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
